Management Team
Ulrich Krasilnikoff
Member of the Board, CEO & CFO 2016-
Born 1967, MBA, Dipl. Ing., CPA
- CEO & CFO Curasight A/S (2016-)
- EVP Biofac Group (pharma; 2015-2016)
- Ass. Partner Capidea Capital Fund (Private equity; 2012-2014)
- Partner/EVP Mezzanin Capital A/S (Private equity; 2004-2012)
- EVP HNC Group A/S (2002-2004)
- Board member; Curasight A/S, Primodan A/S and other companies.
- Certified Public Accountant (CPA) and B.Sc in finance and accounting – Copenhagen Business School (CBS)
- MBA - University of Southern Denmark, Diploma in Engineering from DTU - Technical University of Denmark (DTU)
Andreas Kjær
Member of the Board, CSO and co-founder 2013-
Born 1963, MD, PhD, DMSc, MBA
- CSO and co-founder Curasight (2013-)
- Professor at the University of Copenhagen, Chief Physician at Rigshospitalet - the National University Hospital of Denmark (research focused on molecular imaging with PET and PET/MRI and theranostics in cancer)
- Head of Cluster for Molecular Imaging (CMI) (2004-)
- Holder of an ERC Advanced Grant, has published more than 500 peer-review articles, has received numerous prestigious scientific awards over the years.
- Member of the Danish Academy of Technica Sciences (ATV) (2015-)
- Founder FlouGuide (2018)
- Co-founder Minerva Imaging (2011).
- Founding Editor in Chief Diagnostics (2011-) and International Associate Editor Journal of Nuclear Medicine (2019-)
- MD, PhD, DMSc - University of Copenhagen, Master of Business Administration (MBA) - Copenhagen Business School (CBS)
Hanne Damgaard Jensen
CDO, COO (2022-)
Born 1963, MSc Pharm, MBA
- CDO, COO Curasight (2022-)
- CEO & Founder ROS Therapeutics (2018-)
- Board Chairman AimVion A/S (2020-)
- CDO & CEO Azanta (2009-2017
- MD REGUNIC (2009-)
- SVP Prod. Devpt. Santaris Pharma (2007-8)
- Affairs Mgr to EVP Genmab A/S (1999-2007)
MSc Pharma - School of Pharmaceutical Sciences at University of Copenhagen, MBA -Copenhagen Business School